Climate Change Data

SK bioscience Co., Ltd.

Climate Impact & Sustainability Data (2022)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:18,491 tCO2eq (Scope 1 & 2)
Scope 1 Emissions:5,032 tCO2eq (Andong L HOUSE)
Scope 2 Emissions:11,866 tCO2eq (Andong L HOUSE)
Scope 3 Emissions:112,381 tCO2eq
Renewable Energy Share:38% (2022)
Total Energy Consumption:383.7 TJ
Water Consumption:144,482 t (Andong L HOUSE)
Waste Generated:395.9 t (Andong L HOUSE)
Carbon Intensity:0.040 tCO2eq/KRW 1 million (2022)

ESG Focus Areas

  • Securing Mid-to-long term Growth Engine
  • Talent Acquisition
  • Ensuring Drug Quality and Safety
  • Implementing Business Ethics and Compliance
  • Fair Pricing/Enhancing Access to Vaccines
  • Responding to Climate Change
  • Practicing Human Rights Management
  • Internalizing ESG Management
  • Hazardous Chemical Waste Management
  • Building a Sustainable Supply Chain
  • Transparent/Responsible Management centered on the Board

Environmental Achievements

  • Obtained ISO 14001 certification for Andong L HOUSE in 2022
  • Improved the recycling rate of general waste at Andong L HOUSE by approximately 27.8% year-on-year in 2022
  • Andong L HOUSE applied 16 new eco-friendly technologies, including those that save energy and water resources, achieving up to 30% energy savings compared to conventional methods.

Social Achievements

  • Created a healing program to improve the work-life balance of employees who overworked an average of 38 hours or more per month in 2022
  • Increased the amount of Benefit Allowances for employees’ self-development and living support, and expanded family support such as health checkups and vaccinations in 2022
  • Established the Park Man-Hoon Award with the International Vaccine Institute (IVI)

Governance Achievements

  • Established the ESG Committee under the Board of Directors in 2021
  • Published its first ESG report and a TCFD report in 2022
  • Received Grade A rating on ESG Evaluation for governance from the Korea Institute of Corporate Governance & Sustainability in 2022
  • Revised Human Rights Management Declaration in 2022

Climate Goals & Targets

Long-term Goals:
  • Achieve Net Zero emissions by 2031
Medium-term Goals:
  • Achieve RE100 by 2024
  • Achieve 73% Scope 1&2 reduction by 2024
Short-term Goals:
  • Reduce water consumption
  • Expand hydrogen blending in Andong L HOUSE boilers

Environmental Challenges

  • Climate change impacts on ecosystems and biodiversity loss
  • Securing global talent amid intensifying competition
  • Managing climate change risks that have a direct or indirect impact on both financial and non-financial performance
  • Managing tax risks that may arise due to ongoing changes in tax policies
Mitigation Strategies
  • Established a Net Zero Roadmap to achieve net-zero GHG emissions by 2031
  • Implemented a three-pronged talent development strategy
  • Conducted evaluations of potential climate-related risks considering timeframe, financial implications, and severity
  • Seeks advice on taxes from external tax experts and consults tax authorities in advance for major tax issues

Supply Chain Management

Supplier Audits: 46 suppliers (2022)

Responsible Procurement
  • Supplier Code of Conduct
  • Click ESG platform
  • ESG self-assessment for suppliers

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather events
  • Wildfires
  • Typhoons
  • Torrential downpours
Transition Risks
  • Carbon pricing
  • Increased demand for eco-friendly products
  • Stakeholder pressure for stronger climate action
Opportunities
  • Development of energy-efficient products
  • Strengthening global collaborations

Reporting Standards

Frameworks Used: GRI Standards 2021, SASB Standards, TCFD, UN SDGs

Certifications: ISO 14001, ISO 45001, ISO 27001

Third-party Assurance: British Standards Institution (BSI)

UN Sustainable Development Goals

  • Goal 3
  • Goal 4
  • Goal 5
  • Goal 6
  • Goal 7
  • Goal 8
  • Goal 9
  • Goal 10
  • Goal 11
  • Goal 12
  • Goal 13
  • Goal 15
  • Goal 17

SK bioscience's initiatives contribute to these goals through various activities detailed in the report.

Sustainable Products & Innovation

  • Next-generation pneumococcal vaccine
  • RSV vaccine
  • Nasal spray COVID-19 vaccine

Awards & Recognition

  • Korea Health & Medical Award 2022
  • Minister of Food and Drug Safety Award (MFDS)
  • Medal of Merit for Contributions to 2023 Gyeongbuk Bio Industry Expo
  • Korea Pharmaceutical and Bio/Pharma award
  • Medal of Merit for Contributions to Balanced Regional Industrial Development
  • Medal of Merit for Contributions to Drug Safety and Advancement of the Pharmaceutical Industry
  • Medal of Merit for Contributions to the Promotion of Healthcare
  • Minister’s Citation Medal of Merit for Contributions to Biosecurity Management
  • Korea Biotechnology Industry Organization Chairman’s award
  • Medal of Merit for Contributions to New Growth Management